Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Adding insult to injury: reluctance to engage in clinical research with at-risk groups further disenfranchises these populations.

Lynch HF, Dawson L.

Am J Bioeth. 2009 Nov;9(11):62-4. doi: 10.1080/15265160903197655. No abstract available.

PMID:
19882465
2.

A modest proposal.

Burris S, Davis C.

Am J Bioeth. 2009 Nov;9(11):W3-4. doi: 10.1080/15265160903263481. No abstract available.

PMID:
19882443
3.

Evaluating empirical assessments of social risk.

Schonfeld T, Brown JS.

Am J Bioeth. 2009 Nov;9(11):55-6. doi: 10.1080/15265160903197556. No abstract available.

PMID:
19882461
4.

Deflating rhetoric about "ethical inflation".

Rennie S, Rosenfeld LB.

Am J Bioeth. 2009 Nov;9(11):58-60. doi: 10.1080/15265160903197622. No abstract available.

PMID:
19882463
6.

The need to explicate the ethical evaluation tools to avoid ethical inflation.

Bernabe RD, van Thiel GJ, Raaijmakers JA, van Delden JJ.

Am J Bioeth. 2009 Nov;9(11):56-8. doi: 10.1080/15265160903197606. No abstract available.

PMID:
19882462
7.

Assessing social risks prior to commencement of a clinical trial: due diligence or ethical inflation?

Burris S, Davis C.

Am J Bioeth. 2009 Nov;9(11):48-54. doi: 10.1080/15265160903197507.

PMID:
19882460
8.

The need for evidence-based research ethics.

Anderson EE, Sieber JE.

Am J Bioeth. 2009 Nov;9(11):60-2. doi: 10.1080/15265160903234060. No abstract available.

PMID:
19882464
9.

A step toward truly protecting human subjects: reviewing the review boards.

Albrecht RR.

Am J Bioeth. 2004 Winter;4(1):54-5. No abstract available.

PMID:
15035952
10.

Adolescents as doubly-vulnerable research subjects.

Kopelman LM.

Am J Bioeth. 2004 Winter;4(1):50-2. No abstract available.

PMID:
15035950
11.

How not to rethink research ethics.

Beauchamp TL.

Am J Bioeth. 2005 Winter;5(1):31-3; author reply W15-8. No abstract available.

PMID:
16036653
12.

Does research ethics rest on a mistake? The common good, reasonable risk and social justice.

London AJ.

Am J Bioeth. 2005 Winter;5(1):37-9; author reply W15-8. No abstract available.

PMID:
16036656
13.

Guidelines for IRB review of international collaborative medical research: a proposal.

White MT.

J Law Med Ethics. 1999 Spring;27(1):87-94. No abstract available.

PMID:
11657148
14.

Clinical value: the neglected axis in the system of research ethics.

Karlawish JH.

Account Res. 1999;7(2-4):255-64. No abstract available.

PMID:
11658180
15.

The IRB's role in assessing the generalizability of non-NIH-funded clinical trials.

Weijer C.

IRB. 1998 Mar-Jun;20(2-3):1-5. No abstract available.

PMID:
11656912
16.

A third way: ethics guidance as evidence-informed provisional rules.

Borgerson K, Millum J.

Am J Bioeth. 2010 Jun;10(6):20-2. doi: 10.1080/15265161003702881. No abstract available.

PMID:
20526963
17.

The limitations of "vulnerability" as a protection for human research participants.

Levine C, Faden R, Grady C, Hammerschmidt D, Eckenwiler L, Sugarman J; Consortium to Examine Clinical Research Ethics..

Am J Bioeth. 2004 Summer;4(3):44-9.

PMID:
16192138
18.

The changing clinical trials scene: the role of the IRB.

Mitchell SC, Steingrub J.

IRB. 1988 Jul-Aug;10(4):1-5. No abstract available.

PMID:
11650078
19.

Justice and research design: the case for a semi-randomization clinical trial.

Veatch RM.

Clin Res. 1983 Feb;31(1):12-22. No abstract available.

PMID:
10299203
20.

Some questionable premises about research ethics.

Macklin R.

Am J Bioeth. 2005 Winter;5(1):29-31; author reply W15-8. No abstract available.

PMID:
16036652
Items per page

Supplemental Content

Support Center